By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Southern California’s Keck School of Medicine has landed a $24 million gift from media mogul Sumner Redstone to fund molecular research into prostate cancer, USC said this week.

The research will involve genomics and proteomics and will be led by David Agus, who is director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center and a co-founder of Navigenics, the Keck School of Medicine said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.